Dare Bioscience, Inc. - Common Stock (DARE)
2.3300
+0.0800 (3.56%)
NASDAQ· Last Trade: May 20th, 9:35 PM EDT
Detailed Quote
| Previous Close | 2.250 |
|---|---|
| Open | 2.270 |
| Bid | 2.400 |
| Ask | 2.440 |
| Day's Range | 2.250 - 2.480 |
| 52 Week Range | 1.270 - 9.190 |
| Volume | 309,239 |
| Market Cap | 164.32M |
| PE Ratio (TTM) | -1.239 |
| EPS (TTM) | -1.9 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 875,325 |
Chart
About Dare Bioscience, Inc. - Common Stock (DARE)
Dare Bioscience Inc is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions, particularly in women's health care. The company is dedicated to addressing unmet medical needs by creating products aimed at enhancing reproductive health, contraception, and various gynecological conditions. With a portfolio of proprietary and partnered therapies, Dare Bioscience combines scientific expertise and cutting-edge technologies to deliver effective treatment options that improve the quality of life for women. Read More
News & Press Releases
Daré (DARE) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 15, 2026
Daré Bioscience (NASDAQ:DARE) Q1 2026 Results Show Mixed Bag with Revenue Miss but EPS Beat and Upcoming Product Launcheschartmill.com
Via Chartmill · May 14, 2026
These stocks are moving in today's sessionchartmill.com
Via Chartmill · May 4, 2026
Traders are paying attention to the gapping stocks in Monday's session.chartmill.com
Via Chartmill · May 4, 2026
Unusual volume stocks are being observed in Tuesday's session.chartmill.com
Via Chartmill · April 21, 2026
Unusual volume stocks are being observed in Monday's session.chartmill.com
Via Chartmill · April 20, 2026
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Via Chartmill · April 17, 2026
Daré Bioscience (DARE) Q3 2025 Earnings Transcript
Via The Motley Fool · November 13, 2025
Via Benzinga · September 4, 2025
Via Benzinga · August 14, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · July 15, 2025
Via Benzinga · July 15, 2025
Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.
Via AB Newswire · July 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 14, 2025
Unusual volume stocks in Monday's session
Via Chartmill · July 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 14, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · July 14, 2025
